Skip to main content
Medicine logoLink to Medicine
. 2019 Dec 10;98(49):e18401. doi: 10.1097/MD.0000000000018401

Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report: Erratum

PMCID: PMC6919391  PMID: 31804381

In the article, “Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report”,[1] which appears in Volume 98, Issue 45 of Medicine, the second quotation in 4.2. Ethical approval is written incorrectly and should be “different indication in term of medical condition than the one described in the authorised product information; a different group of patients than the one described in the authorised product information; a different route or method of administration than the one described in the authorised product information; a different posology than the one described in the authorized product information.”

Footnotes

How to cite this article: Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report. Medicine. 2019;98:49(e18401).

Reference

  • [1].Proboka G, Rasa A, Olmane E. Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report. Medicine. 98;45:e17883. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES